GZERO Daily: the newsletter for people who love global politics
Sign up for our free newsletter to keep up with what’s going on around the world - and why it matters.
GZERO Daily: the newsletter for people who love global politics
We have updated our Privacy Policy and Terms of Use for Eurasia Group and its affiliates, including GZERO Media, to clarify the types of data we collect, how we collect it, how we use data and with whom we share data. By using our website you consent to our Terms and Conditions and Privacy Policy, including the transfer of your personal data to the United States from your country of residence, and our use of cookies described in our Cookie Policy.
{{ subpage.title }}
Coronavirus' effect on health may linger; expert warns of more patients with both flu and Covid-19
November 29, 2020
November 29, 2020 3:04 PM
BEIJING (CHINA DAILY/ASIA NEWS NETWORK) - Covid-19 and related diseases may cause lasting health problems, with more than 70 per cent of patients who have recovered still showing at least one symptom after they are well, according to a study.
BEIJING (CHINA DAILY/ASIA NEWS NETWORK) - Covid-19 and related diseases may cause lasting health problems, with more than 70 per cent of patients who have recovered still showing at least one symptom after they are well, according to a study.
Indian scientists develop new paper-strip test for Covid 19
October 14, 2020
October 15, 2020 5:00 AM
A fast and easy paper-strip test for Covid 19, much like a pregnancy test, is set to hit the market, and it could be a game changer for India as it seeks to curb the coronavirus pandemic.
A fast and easy paper-strip test for Covid 19, much like a pregnancy test, is set to hit the market, and it could be a game changer for India as it seeks to curb the coronavirus pandemic.
Takeda-led Covid-19 plasma treatment enters clinical trial with first patient
October 09, 2020
October 09, 2020 10:39 AM
TOKYO (REUTERS) - Japan's Takeda Pharmaceutical Co said on Friday (Oct 9) an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for Covid-19 after months of regulatory delays.
TOKYO (REUTERS) - Japan's Takeda Pharmaceutical Co said on Friday (Oct 9) an alliance of drugmakers it spearheads has enrolled its first patient in a global clinical trial of a blood plasma treatment for Covid-19 after months of regulatory delays.
Coronavirus: One in three South Korean Covid-19 patients improve with remdesivir drug
July 13, 2020
July 13, 2020 12:48 PM
SEOUL (REUTERS) - One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences's antiviral remdesivir, health authorities said.
SEOUL (REUTERS) - One in three South Korean patients seriously ill with Covid-19 showed an improvement in their condition after being given Gilead Sciences's antiviral remdesivir, health authorities said.
Global trial of anti-malarial drug backed by Trump stalls
May 27, 2020
May 28, 2020 5:00 AM
Recruitment of subjects for a major global trial to determine whether an anti-malarial drug can ward off the coronavirus has stalled, after the World Health Organisation (WHO) suspended its own clinical trials on treating Covid-19 patients.
Recruitment of subjects for a major global trial to determine whether an anti-malarial drug can ward off the coronavirus has stalled, after the World Health Organisation (WHO) suspended its own clinical trials on treating Covid-19 patients.
Thailand cautiously reopens door to weed
June 05, 2019
June 06, 2019 5:00 AM
NAKHON RATCHASIMA (Thailand)• • "Would you like to try it?" the young man says when he notices me peering at the cannabis joint held between his fingers. "It's good for your health." Behind him, a dark green banner declares: "Meet People with Experience in Kancha".
NAKHON RATCHASIMA (Thailand)• • "Would you like to try it?" the young man says when he notices me peering at the cannabis joint held between his fingers. "It's good for your health." Behind him, a dark green banner declares: "Meet People with Experience in Kancha".